|
Phase II Trial of ASM8 in Asthma Commences
irasia.com (press release) Pharmaceutical company Pharmaxis (ASX: PXS) today announced it had enrolled the first subjects into a Phase II clinical trial evaluating the new asthma drug … |
View full post on asthma – Google News